However, only ERK1/2 and PI3 K/Akt inhibitors significantly reduced the secretion of VEGF by uveal melanoma cells, whereas JNK1/2 and p38 inhibitors did not influence the secretion of VEGF by melanoma cells in the present study. The gene discussed is MAPK3; the disease is uveal melanoma.